Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jonathan S. Coblyn is active.

Publication


Featured researches published by Jonathan S. Coblyn.


NEJM Journal Watch | 2018

Pneumonia Prophylaxis Benefits Patients with Rheumatic Diseases

Jonathan S. Coblyn

Pneumocystis pneumonia (PCP) prophylaxis is effective in HIV-positive patients and other immunosuppressed groups, but consensus is lacking on PCP


NEJM Journal Watch | 2018

Autologous Stem-Cell Transplantation vs. Cyclophosphamide in Patients with Severe Scleroderma

Jonathan S. Coblyn

Patients with diffuse scleroderma often have poor prognoses. Therapies generally have targeted specific organ involvement (e.g.,


NEJM Journal Watch | 2018

Good News for Rheumatoid Arthritis Patients Who Like to Eat Fish

Jonathan S. Coblyn

Many ω-3 fatty acids downregulate proinflammatory cytokines; therefore, researchers have evaluated their effect in patients with rheumatoid arthritis


NEJM Journal Watch | 2018

Some Patients with Femoroacetabular Impingement Might Benefit from Hip Arthroscopy

Jonathan S. Coblyn

Femoroacetabular impingement is caused by premature contact between the femur and acetabulum during hip movements and can be associated with hip


NEJM Journal Watch | 2018

Long-Term Risk for Gout, According to Baseline Uric Acid Levels

Jonathan S. Coblyn

Elevated uric acid levels are a key risk factor for developing gout. However, the actual frequency of gout attacks relative to uric acid concentration


NEJM Journal Watch | 2018

Effectiveness of Physical Therapy vs. Arthroscopy for Meniscal Tears

Jonathan S. Coblyn

Despite good evidence showing that arthroscopic partial menisectomy (APM) is not better than physical therapy (PT) for meniscal tears, APM continues to


NEJM Journal Watch | 2018

Another Reason to Encourage RA Patients to Stop Smoking

Jonathan S. Coblyn

Despite all the health warnings about smoking, as of 2014, 16.8% of U.S. residents were smokers. Smoking cessation leads to lower early mortality among


NEJM Journal Watch | 2017

Allopurinol, Febuxostat, and Risk for Renal Disease

Jonathan S. Coblyn

Whether elevated uric acid is a result of chronic kidney disease or whether renal function itself is worsened by hyperuricemia has long been debated.


NEJM Journal Watch | 2017

Cost-Effectiveness of Biologic Therapy vs. Triple Therapy for Rheumatoid Arthritis

Jonathan S. Coblyn

The standard of care for rheumatoid arthritis (RA) patients who respond inadequately to initial methotrexate therapy is to add either an anti–tumor


NEJM Journal Watch | 2017

Is Joint Aspiration or Injection Safe in Patients Taking Direct-Acting Oral Anticoagulants?

Jonathan S. Coblyn

Some practitioners are reluctant to perform joint aspiration or injection procedures in anticoagulated patients because of heightened risk for

Collaboration


Dive into the Jonathan S. Coblyn's collaboration.

Researchain Logo
Decentralizing Knowledge